Article
Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand
1 Jan 2021
Abstract excerpt
Knowledge about the peptide repertoire presented by human leukocyte antigens (HLA) holds the key to unlock target-specific cancer immunotherapies such as adoptive cell therapies or bispecific T cell engaging receptors. Therefore, comprehensive and accurate characterization of HLA peptidomes by mass spectrometry (immunopeptidomics) across tissues and disease states is essential. With growing numbers of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
